Our Sustainability Report is an important element of our sustainability strategy, which has developed alongside a rapid transformation of our business and our markets. During this time, we have sought to embed sustainability into everything we do, across our global operations and in our products and solutions for customers. Most significant among these was our development of enzymatic processes in the production of antibiotics in the 1990s, which led to major improvements in the environmental performance of our portfolio.
This annually published report is a summary of our performance against stated objective and is inspired by the GRI framework for sustainability reporting. Its contents are testimony to the great work that our people and partners in the supply chain have been carrying out to reduce production impact on the environment and meet our responsibilities towards customers, policy makers, medical professionals, and society at large.